NMRA
Neumora TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
NMRA vs peer average
62/100
NMRA vs. peer average (C vs. D)
Grade spread
A 2 · C 1 · D 4 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
RCKT is the first available peer comparator.
Clinical-stage biotech peer useful for framing binary readout risk and rerating behavior after pivotal or near-pivotal events, though the mechanism and disease mix differ.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NMRA
Neumora Therapeutics
RCKT
Rocket
Grade
C
A
Momentum
98
76
Value
41
41
Sentiment
21
77
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs RCKT
NMRA / RCKT
Grade Position
In line
NMRA vs. peer average (C vs. D)
62/100
Momentum
98
NMRAValue
41
NMRASentiment
21
RCKTRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NMRA
RCKT is the first peer returned for this comparison set.